Practical management of nocturia in urology

Myeong Heon Jin, Du Geon Moon

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Until last decades, nocturia has been considered as an irritative symptom of benign prostatic hyperplasia (BPH), but the nocturia is unresponsive symptoms to various modalities of BPH treatment. More recently, it has been recognized that the prostate is not so quite important as previously believed, as nocturia is equally common in women. The understanding of nocturia has been much changed in last decade; it is a highly prevalent condition, and symptoms in men and women are really no different either quantitatively or qualitatively. The successful introduction of desmopressin (l-deamino-8-D-arginine vasopressin, DDAVP) to decrease nocturnal urine output in severe nocturia which resistant to conventional BPH treatment and in women demonstrated new perspectives in management of nocturia. We reviewed the definition and etiologies of nocturia, offering the current diagnostic procedures and standards of care.

Original languageEnglish
Pages (from-to)289-294
Number of pages6
JournalIndian Journal of Urology
Volume24
Issue number3
DOIs
Publication statusPublished - 2008 Jul 1

Fingerprint

Nocturia
Urology
Prostatic Hyperplasia
Deamino Arginine Vasopressin
Arginine Vasopressin
Standard of Care
Prostate
Urine
Therapeutics

Keywords

  • Nocturia
  • Review
  • Urology

ASJC Scopus subject areas

  • Urology

Cite this

Practical management of nocturia in urology. / Jin, Myeong Heon; Moon, Du Geon.

In: Indian Journal of Urology, Vol. 24, No. 3, 01.07.2008, p. 289-294.

Research output: Contribution to journalReview article

Jin, Myeong Heon ; Moon, Du Geon. / Practical management of nocturia in urology. In: Indian Journal of Urology. 2008 ; Vol. 24, No. 3. pp. 289-294.
@article{83f4e9ecc9e74d53b777f5f27399a886,
title = "Practical management of nocturia in urology",
abstract = "Until last decades, nocturia has been considered as an irritative symptom of benign prostatic hyperplasia (BPH), but the nocturia is unresponsive symptoms to various modalities of BPH treatment. More recently, it has been recognized that the prostate is not so quite important as previously believed, as nocturia is equally common in women. The understanding of nocturia has been much changed in last decade; it is a highly prevalent condition, and symptoms in men and women are really no different either quantitatively or qualitatively. The successful introduction of desmopressin (l-deamino-8-D-arginine vasopressin, DDAVP) to decrease nocturnal urine output in severe nocturia which resistant to conventional BPH treatment and in women demonstrated new perspectives in management of nocturia. We reviewed the definition and etiologies of nocturia, offering the current diagnostic procedures and standards of care.",
keywords = "Nocturia, Review, Urology",
author = "Jin, {Myeong Heon} and Moon, {Du Geon}",
year = "2008",
month = "7",
day = "1",
doi = "10.4103/0970-1591.42607",
language = "English",
volume = "24",
pages = "289--294",
journal = "Indian Journal of Urology",
issn = "0970-1591",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "3",

}

TY - JOUR

T1 - Practical management of nocturia in urology

AU - Jin, Myeong Heon

AU - Moon, Du Geon

PY - 2008/7/1

Y1 - 2008/7/1

N2 - Until last decades, nocturia has been considered as an irritative symptom of benign prostatic hyperplasia (BPH), but the nocturia is unresponsive symptoms to various modalities of BPH treatment. More recently, it has been recognized that the prostate is not so quite important as previously believed, as nocturia is equally common in women. The understanding of nocturia has been much changed in last decade; it is a highly prevalent condition, and symptoms in men and women are really no different either quantitatively or qualitatively. The successful introduction of desmopressin (l-deamino-8-D-arginine vasopressin, DDAVP) to decrease nocturnal urine output in severe nocturia which resistant to conventional BPH treatment and in women demonstrated new perspectives in management of nocturia. We reviewed the definition and etiologies of nocturia, offering the current diagnostic procedures and standards of care.

AB - Until last decades, nocturia has been considered as an irritative symptom of benign prostatic hyperplasia (BPH), but the nocturia is unresponsive symptoms to various modalities of BPH treatment. More recently, it has been recognized that the prostate is not so quite important as previously believed, as nocturia is equally common in women. The understanding of nocturia has been much changed in last decade; it is a highly prevalent condition, and symptoms in men and women are really no different either quantitatively or qualitatively. The successful introduction of desmopressin (l-deamino-8-D-arginine vasopressin, DDAVP) to decrease nocturnal urine output in severe nocturia which resistant to conventional BPH treatment and in women demonstrated new perspectives in management of nocturia. We reviewed the definition and etiologies of nocturia, offering the current diagnostic procedures and standards of care.

KW - Nocturia

KW - Review

KW - Urology

UR - http://www.scopus.com/inward/record.url?scp=50949117550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50949117550&partnerID=8YFLogxK

U2 - 10.4103/0970-1591.42607

DO - 10.4103/0970-1591.42607

M3 - Review article

C2 - 19468456

AN - SCOPUS:50949117550

VL - 24

SP - 289

EP - 294

JO - Indian Journal of Urology

JF - Indian Journal of Urology

SN - 0970-1591

IS - 3

ER -